The estimated Net Worth of Kees J Storm is at least $2.77 Million dollars as of 28 March 2018. Kees Storm owns over 47,959 units of Baxter International stock worth over $2,767,396 and over the last 22 years Kees sold BAX stock worth over $0.
Kees has made over 7 trades of the Baxter International stock since 2012, according to the Form 4 filled with the SEC. Most recently Kees exercised 47,959 units of BAX stock worth $1,654,106 on 28 March 2018.
The largest trade Kees's ever made was exercising 47,959 units of Baxter International stock on 28 March 2018 worth over $1,654,106. On average, Kees trades about 3,600 units every 93 days since 2003. As of 28 March 2018 Kees still owns at least 70,471 units of Baxter International stock.
You can see the complete history of Kees Storm stock trades at the bottom of the page.
Kees's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney, and Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: